Merck & Co. Dividends payable increased by 4.8% to $2.14B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $2.08B to $2.14B. Over 5 years (FY 2020 to FY 2025), Dividends payable shows an upward trend with a 5.0% CAGR.
An increase indicates a recent declaration of dividends, while a decrease suggests recent payment or a change in dividend policy.
This represents the total amount of cash dividends that have been formally declared by the board of directors but have n...
Standard across all dividend-paying public companies, typically reflecting the frequency of dividend cycles.
dividends_payable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.66B | $1.66B | $1.77B | $1.77B | $1.77B | $1.77B | $1.88B | $1.91B | $1.88B | $1.88B | $1.99B | $2.01B | $1.98B | $1.98B | $2.08B | $2.08B | $2.05B | $2.04B | $2.14B |
| QoQ Change | — | -0.1% | +6.5% | +0.2% | -0.2% | +0.2% | +6.4% | +1.2% | -1.6% | +0.0% | +5.8% | +1.2% | -1.3% | +0.1% | +5.1% | -0.3% | -1.2% | -0.5% | +4.8% |
| YoY Change | — | — | — | — | +6.4% | +6.7% | +6.6% | +7.7% | +6.2% | +6.0% | +5.4% | +5.3% | +5.5% | +5.6% | +5.0% | +3.4% | +3.6% | +3.0% | +2.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.